Vitamin Shoppe (NYSE:VSI) is scheduled to issue its quarterly earnings data before the market opens on Wednesday, May 8th.
Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings results on Tuesday, February 26th. The specialty retailer reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.31) by $0.12. The firm had revenue of $248.46 million during the quarter, compared to analyst estimates of $255.79 million. Vitamin Shoppe had a positive return on equity of 3.24% and a negative net margin of 0.34%. On average, analysts expect Vitamin Shoppe to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
VSI opened at $5.93 on Tuesday. The company has a quick ratio of 0.29, a current ratio of 2.08 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $149.97 million, a PE ratio of 24.04 and a beta of 1.35. Vitamin Shoppe has a 1 year low of $4.27 and a 1 year high of $13.95.
A number of brokerages have weighed in on VSI. ValuEngine raised Vitamin Shoppe from a “hold” rating to a “buy” rating in a research report on Friday, March 1st. Barclays raised Vitamin Shoppe from an “underweight” rating to an “equal weight” rating in a research report on Tuesday, January 8th. Finally, Zacks Investment Research lowered Vitamin Shoppe from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 1st.
Vitamin Shoppe Company Profile
Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.
Recommended Story: NASDAQ Stock Market Explained
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.